Additionally, the Huangkui capsule counteracts tubular epithelial-to-mesenchymal transition (EMT) induced by NLRP3 inflammatory vesicle activation through the TLR4/NF-κB signaling pathway, thus contributing to the alleviation of renal fibrosis (99). This evidence concerns the gene NLRP3 and renal fibrosis.